Anti-JCV Antibody Prevalence in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-2

被引：0
|
作者：
Bozic, Carmen [1 ]
Richman, Sandra [1 ]
Plavina, Tatiana [1 ]
Natarajan, Amy [1 ]
Scanlon, James [2 ]
Subramanyam, Meena [3 ]
Sandrock, Alfred [3 ]
Bloomgren, Gary [3 ]
机构：
[1] Biogen Idec Inc, Weston, MA USA
[2] Biogen Idec Inc, Boston, MA USA
[3] Biogen Idec Inc, Cambridge, MA USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S41002
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prevalence of Anti-JCV Antibodies in MS Patients Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-1
    Bozic, Carmen
    Richman, Sandra
    Plavina, Tatiana
    Natarajan, Amy
    Subramanyam, Meena
    NEUROLOGY, 2011, 76 (09) : A598 - A598
  • [2] Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab
    Edanur Şahin
    Tuncay Gündüz
    Ahmed Serkan Emekli
    Mazlum Ercanoğlu
    Sevda Öztürk Erden
    Murat Kürtüncü
    Neurological Sciences, 2025, 46 (4) : 1799 - 1805
  • [3] Anti-JCV antibody serology is associated with CSF cell counts in multiple sclerosis patients with and without natalizumab treatment
    Schneider-Hohendorf, T.
    Schulte-Mecklenbeck, A.
    Ostkamp, P.
    Luessi, F.
    Klotz, L.
    Zipp, F.
    Wiendl, H.
    Gross, C. C.
    Schwab, N.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1007 - 1007
  • [4] Longitudinal Analysis of Anti-JCV Antibody Index in Natalizumab-Treated Multiple Sclerosis Patients
    McGurgan, Iain
    Lockhart, Andrew
    Hutchinson, Michael
    McGuigan, Christopher
    NEUROLOGY, 2016, 86
  • [5] Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab
    Sgarlata, Eleonora
    Chisari, Clara Grazia
    D'Amico, Emanuele
    Millefiorini, Enrico
    Patti, Francesco
    CNS DRUGS, 2020, 34 (05) : 535 - 543
  • [6] Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab
    Eleonora Sgarlata
    Clara Grazia Chisari
    Emanuele D’Amico
    Enrico Millefiorini
    Francesco Patti
    CNS Drugs, 2020, 34 : 535 - 543
  • [7] Evaluating results of blood serum anti-JCV antibodies of natalizumab treated multiple sclerosis patients
    Kalamatas, T.
    Protopapas, N.
    Lafionati, A.
    Nella, A.
    Graigos, A.
    Karageorgiou, K.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 458 - 458
  • [8] Anti-JCV Antibody Prevalence in a French Cohort of MS Patients under Natalizumab
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Zephir, Helene
    Collongues, Nicolas
    Lacour, Arnaud
    Fleury, Marie
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Giroux, Marianne
    Vermersch, Patrick
    De Seze, Jerome
    NEUROLOGY, 2012, 78
  • [9] Analysis of Anti-JCV antibody in Japanese patients with multiple sclerosis
    Aoyama, S.
    Mori, M.
    Uchida, T.
    Masuda, H.
    Ohtani, R.
    Sugimoto, K.
    Liu, J.
    Kuwabara, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 238 - 239
  • [10] No changes in anti-JCV antibody status after Natalizumab discontinuation in a large population of Multiple Sclerosis patients
    Sgarlata, E.
    Chisari, C. G.
    D'Amico, E.
    Toscano, S.
    Zanghi, A.
    Lo Fermo, S.
    Patti, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 325 - 325
12345